Drug Trial Radar · NCT00355368
Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care
Last checked: Nov 20, 2026Latest source record: Dec 15, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
420
Actual
Start
Aug 2006
Primary completion
Aug 2006
Study completion Jul 2010
Sponsor
- Lead sponsor
- University Hospital, Basel, SwitzerlandAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 21, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Emergency intubation of patients in intensive care is a high-risk endeavour. For many decades, succinylcholine has been the neuromuscular blocking agent of choice. However, succinylcholine may have life-threatening side effects and is contraindicated in a variety of diseases relevant in intensive care. The nondepolarizing agent rocuronium has been propagated as alternative for succinylcholine. Though a recent meta-analysis found no difference in intubating conditions between succinylcholine and rocuronium in elective cases, there are no data in emergent cases in intensive care. The aim of the present study is to compare succinylcholine and rocuronium with regard to 1) quality of intubating conditions, 2) length of the intubating sequence, 3) failed intubating attempts, 4) hemodynamic sequelae of intubation, and 5) desaturations.
Conditions
- Intubation
Interventions
SuccinylcholineDrug
1mg/kg iv
RocuroniumDrug
0.6mg/kg iv
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Exhibiting Desaturation >5%Time frame: at any time between the start of the intubation sequence and 2min after the completion of intubation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Medical Intensive Care; University of Basel
Basel, Canton of Basel-City, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.